Fusion Pharmaceuticals Inc (FUSN)
21.49
-0.04
(-0.19%)
USD |
NASDAQ |
May 21, 16:00
21.50
0.00 (0.00%)
After-Hours: 20:00
Fusion Pharmaceuticals Cash from Operations (Quarterly): -27.31M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -27.31M |
December 31, 2023 | -17.94M |
September 30, 2023 | -18.84M |
June 30, 2023 | -19.58M |
March 31, 2023 | -25.44M |
December 31, 2022 | -19.36M |
September 30, 2022 | -21.62M |
June 30, 2022 | -17.32M |
March 31, 2022 | -14.97M |
December 31, 2021 | -16.33M |
September 30, 2021 | -21.51M |
Date | Value |
---|---|
June 30, 2021 | -17.31M |
March 31, 2021 | -20.60M |
December 31, 2020 | -3.082M |
September 30, 2020 | -12.87M |
June 30, 2020 | -6.197M |
March 31, 2020 | -7.62M |
December 31, 2019 | -3.833M |
September 30, 2019 | -3.028M |
June 30, 2019 | -4.001M |
March 31, 2019 | -2.828M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-27.31M
Minimum
Mar 2024
-3.028M
Maximum
Sep 2019
-14.94M
Average
-17.31M
Median
Cash from Operations (Quarterly) Benchmarks
AstraZeneca PLC | 2.486B |
Landos Biopharma Inc | -8.498M |
Perspective Therapeutics Inc | 13.85M |
Acasti Pharma Inc | -1.892M |
Aurinia Pharmaceuticals Inc | 14.31M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -70.37M |
Cash from Financing (Quarterly) | 64.01M |
Free Cash Flow | -87.67M |
Free Cash Flow Per Share (Quarterly) | -0.3419 |
Free Cash Flow Yield | -5.58% |